Searched for
MD SHARVIL PATEL
Zydus gets USFDA's orphan drug designation for beta-thalassemia productZydus Lifesciences announced a significant development for beta-thalassemia patients. The US Food and Drug Administration has granted Orpha...
Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new presidentThe Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Gle...
IPA names Zydus Lifesciences MD Sharvil Patel as PresidentSharvil Patel is the new president of the Indian Pharmaceutical Alliance. He takes over from Samir Mehta. Glenn Saldanha becomes the vice p...
Zydus working on single pen device for adjustable Semaglutide dosesZydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It targets both d...
Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
Zydus Lifesciences in pact with Synthon for specialty oncology product in USZydus Lifesciences has signed an exclusive agreement with Synthon for the development and commercialisation of a novel oncology product, fo...
Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
Zydus Q4 Results: Net profit surges 4-fold to Rs 1,182 crore; revenue at Rs 5,534 crZydus Lifesciences on Friday said its consolidated net profit surged four-fold to Rs 1,182 crore for the fourth quarter ended March 31, 202...
Zydus Lifesciences Q1 Results: Net profit doubles to Rs 1,087 crore, revenue jumps 30%US business grew by 57% YoY at Rs 2454 crores. India branded formulations grew by almost 12%, excluding impact of NLEM related price cut af...
Zydus buys rights from Pharmacosmos to sell drug to treat anemia in India, NepalMonoFerric injection is a rapid, single dose intravenous therapy used for the treatment of iron deficiency in adult patients when oral iron...
SEC to take up Zydus Cadila's EUA application this week, says officialZydus developed the vaccine, ZyCov-D with the support of the central government’s Department of Biotechnology and the Indian Council of Med...
‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these ...
145 of India’s top 500 companies have CMD post, must rejig the topIn the sample, 36 companies had market cap above Rs 20,000 crore.
Biologics and vaccines businesses will be significant growth drivers post 2022: Sharvil Patel, CadilaWe have a healthy list of ANDAs that have been filed and coming up for approval.
Cadila's new MD Sharvil Patel aims to double revenues in 5 yearsWith a doctoral degree from University of Sunderland, Sharvil is the third generation Patel to lead Cadila. The company was founded by his ...
Pankaj Patel steps down as Cadila MD, son Sharvil to take overThe Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel as the Manging Director of the comp...